Repligen Corp
NASDAQ:RGEN

Watchlist Manager
Repligen Corp Logo
Repligen Corp
NASDAQ:RGEN
Watchlist
Price: 142.58 USD 0.58% Market Closed
Market Cap: 8B USD
Have any thoughts about
Repligen Corp?
Write Note

Wall Street
Price Targets

RGEN Price Targets Summary
Repligen Corp

Wall Street analysts forecast RGEN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RGEN is 197.31 USD with a low forecast of 161.6 USD and a high forecast of 236.25 USD.

Lowest
Price Target
161.6 USD
13% Upside
Average
Price Target
197.31 USD
38% Upside
Highest
Price Target
236.25 USD
66% Upside

RGEN Last Price Targets
Repligen Corp

The latest public price target was made on Nov 12, 2024 by Paul Knight from KeyBanc , who expects RGEN stock to rise by 54% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Paul Knight
KeyBanc
220 USD
Upside 54%
1 week ago
Nov 12, 2024
KeyBanc Reiterates Overweight Rating on Repligen (RGEN)
StreetInsider
Elizabeth Garcia
UBS
185 USD
Upside 30%
3 months ago
Jul 31, 2024
These Analysts Revise Their Forecasts On Repligen Following Q2 Results
Benzinga
Rachel Vatnsdal
J.P. Morgan
200 USD
Upside 40%
3 months ago
Jul 31, 2024
These Analysts Revise Their Forecasts On Repligen Following Q2 Results
Benzinga
Justin Bowers
Deutsche Bank
155 USD
Upside 9%
4 months ago
Jun 26, 2024
Deutsche Bank Upgrades Repligen (RGEN) to Buy
StreetInsider
Daniel Arias
Stifel Nicolaus
207 USD
Upside 45%
5 months ago
Jun 21, 2024
Stifel Out Positive on Repligen (RGEN): 'current levels seem as though they will have proven to be good ones'
StreetInsider
Paul Knight
KeyBanc
Price Target 220 USD
Upside/Downside 54%
View Source
Elizabeth Garcia
UBS
Price Target 185 USD
Upside/Downside 30%
View Source
Rachel Vatnsdal
J.P. Morgan
Price Target 200 USD
Upside/Downside 40%
View Source
Justin Bowers
Deutsche Bank
Price Target 155 USD
Upside/Downside 9%
View Source
Daniel Arias
Stifel Nicolaus
Price Target 207 USD
Upside/Downside 45%
View Source
Repligen Corp Competitors:
Price Targets
INNOVACAP
Innova Captab Ltd
4% Upside
RVU
Ryvu Therapeutics SA
81% Upside
PPGN
PolyPeptide Group AG
17% Upside
NEO
Neogenomics Inc
28% Upside
SYNGENE
Syngene International Ltd
2% Downside
TECH
Bio-Techne Corp
22% Upside
BIO
Bio Rad Laboratories Inc
22% Upside
MCAP
MedCap AB (publ)
3% Downside

Revenue
Forecast

Revenue Estimate
Repligen Corp

For the last 8 years the compound annual growth rate for Repligen Corp's revenue is 29%. The projected CAGR for the next 3 years is 9%.

29%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Repligen Corp

For the last 8 years the compound annual growth rate for Repligen Corp's operating income is 22%. The projected CAGR for the next 3 years is 22%.

22%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-18%
Average Miss

Net Income
Forecast

Net Income Estimate
Repligen Corp

For the last 8 years the compound annual growth rate for Repligen Corp's net income is 21%. The projected CAGR for the next 3 years is 47%.

21%
Past Growth
47%
Estimated Growth
Estimates Accuracy
-52%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RGEN's stock price target?
Price Target
197.31 USD

According to Wall Street analysts, the average 1-year price target for RGEN is 197.31 USD with a low forecast of 161.6 USD and a high forecast of 236.25 USD.

What is Repligen Corp's Revenue forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for Repligen Corp's revenue is 29%. The projected CAGR for the next 3 years is 9%.

What is Repligen Corp's Operating Income forecast?
Projected CAGR
22%

For the last 8 years the compound annual growth rate for Repligen Corp's operating income is 22%. The projected CAGR for the next 3 years is 22%.

What is Repligen Corp's Net Income forecast?
Projected CAGR
47%

For the last 8 years the compound annual growth rate for Repligen Corp's net income is 21%. The projected CAGR for the next 3 years is 47%.

Back to Top